Compare CVS Health Corp (CVS) vs Open Text Corporation (OTEX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Open Text Corporation — how do they compare? CVS Health Corp trades at $93.65 (market cap $122.36B), while Open Text Corporation trades at $24.05 (market cap $5.98B). The key difference: CVS Health Corp is far larger — about 20.5× Open Text Corporation's market cap, and Open Text Corporation pays the higher dividend (4.53%). Which is the better fit depends on your goals.
| CVS | OTEX | |
|---|---|---|
Market Cap | $122.36B | $5.98B |
Sector | Health | Technology |
52-Week High | $110.60 | $39.69 |
52-Week Low | $65.51 | $20.01 |
Enterprise Value | $184.71B | $11.00B |
Dividend Yield | 2.78% | 4.53% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $95.70, down 0.54% on the day, with a bearish technical signal and key support at $95. The company reported strong Q2 2026 earnings, beating estimates with EPS of $2.58 versus $1.87 expected, and raised its full-year guidance. Revenue growth remains robust, reaching $402.07 billion in 2025, though net income margin compressed to 1.18%. Analyst sentiment is overwhelmingly positive with a consensus price target of $115.00.
The outlook for CVS is cautiously optimistic, driven by operational improvements in its Aetna segment and raised cash flow guidance. Investment opportunities include potential upside to the consensus target, but risks involve margin pressures, regulatory changes impacting pharmacy benefits in 2027, and high debt levels. The stock's current valuation at a P/E of 25.25 may limit near-term gains if earnings growth slows.
Open Text Corporation (OTEX) trades at $24.94, down 2.81% in the last session, with a bullish technical signal from moving averages and strong support at $24. The company reported Q2 2026 EPS of $1.23, beating estimates, and maintains robust profitability with a 73.74% gross margin. Recent news highlights cloud revenue growth and a $105 million AI investment in Europe, signaling strategic expansion.
OTEX presents a value opportunity with a low P/E of 9.58 and a consensus price target of $29.33, implying 17.6% upside. Risks include high long-term debt of $6.34 billion and competitive pressures in software. Analyst sentiment is mixed, with 42% buy ratings, but earnings beats and dividend stability support a constructive outlook for patient investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Open Text Corporation
Open Text Corporation is a global leader in Enterprise Information Management (EIM) software and solutions. The company provides a comprehensive platform that helps organizations manage, secure, and leverage their unstructured digital content, including documents, emails, and media files. OTEX's offerings span content management, business process management, customer experience management, and security, serving large enterprises across various industries worldwide.
Read more on OTEX →
